Your browser doesn't support javascript.
loading
Dose-escalation part of Phase I study of single-agent mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
Munakata, Wataru; Izutsu, Koji; Mishima, Yuko; Nagai, Hirokazu; Ishihara, Yuko; Suzumiya, Junji; Kanakura, Yuzuru; Nanki, Toshihiro; Miyake, Takeshi; Kawasaki, Atsuko; Yoshinaga, Tatsuya; Ishizawa, Kenichi.
Affiliation
  • Munakata W; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Mishima Y; Department of Hematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Ishihara Y; Department of Hematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Suzumiya J; Department of Hematology, Koga Community Hospital, Shizuoka, Japan.
  • Kanakura Y; Department of Hematology, Sumitomo Hospital, Osaka, Japan.
  • Nanki T; Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
  • Miyake T; Pharmaceutical Science Department, Chugai Pharmaceutical Co, Ltd, Tokyo, Japan.
  • Kawasaki A; Biometrics Department, Chugai Pharmaceutical Co, Ltd, Tokyo, Japan.
  • Yoshinaga T; Clinical Development Department, Chugai Pharmaceutical Co, Ltd, Tokyo, Japan.
  • Ishizawa K; Department of Third Internal Medicine, Yamagata University Hospital, Yamagata, Japan.
Jpn J Clin Oncol ; 53(10): 912-921, 2023 Oct 04.
Article in En | MEDLINE | ID: mdl-37486002

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Follicular / Antineoplastic Agents Limits: Female / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Follicular / Antineoplastic Agents Limits: Female / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: